Study With Immunotherapy Combinations in Participants With Metastatic Non-Small Cell Lung Cancer
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Location
- at La Jolla, California and other locations
- Dates
- study startedcompletion around
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- accepting new patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Gilead Sciences
- ID
- NCT05676931
- Phase
- Phase 2 research study
- Study Type
- Interventional
- Participants
- Expecting 320 study participants
- Last Updated